BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 24146927)

  • 21. Local and systemic release of cytokines, nerve growth factor, prostaglandin E2, and substance P in incisional wounds and serum following cesarean delivery.
    Carvalho B; Clark DJ; Angst MS
    J Pain; 2008 Jul; 9(7):650-7. PubMed ID: 18394968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β-catenin signal.
    Fang W; Song Q; Lv T; Lv J; Cai Z; Wang Z; Song X; Ji X; Huang J
    Int Urol Nephrol; 2023 Dec; 55(12):3065-3075. PubMed ID: 37594700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.
    Jiang YH; Liu HT; Kuo HC
    PLoS One; 2014; 9(3):e91609. PubMed ID: 24614892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary IL-33 and galectin-3 increase in patients with interstitial cystitis/bladder pain syndrome (review).
    Kochiashvili G; Kochiashvili D
    Georgian Med News; 2014; (232-233):12-5. PubMed ID: 25214264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 4 and comorbid pain in Interstitial Cystitis/Bladder Pain Syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study.
    Schrepf A; Bradley CS; O'Donnell M; Luo Y; Harte SE; Kreder K; Lutgendorf S;
    Brain Behav Immun; 2015 Oct; 49():66-74. PubMed ID: 25771510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
    Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
    Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of key pathways and mRNAs in interstitial cystitis/bladder pain syndrome treatment with quercetin through bioinformatics analysis of mRNA-sequence data.
    Wang G; Li P; Su SW; Xu R; Huang ZY; Yang TX; Li JM
    Aging (Albany NY); 2024 Mar; 16(7):5949-5966. PubMed ID: 38526326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between a pro- and anti-inflammatory cytokine imbalance and depression in haemodialysis patients.
    Taraz M; Khatami MR; Gharekhani A; Abdollahi A; Khalili H; Dashti-Khavidaki S
    Eur Cytokine Netw; 2012; 23(4):179-86. PubMed ID: 23360798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum sphingosine-1-phosphate levels in bladder pain syndrome/interstitial cystitis patients: could it help in diagnosis?
    Asi T; Asci A; Altan M; Gudeloglu A; Ergen A
    World J Urol; 2020 Oct; 38(10):2577-2581. PubMed ID: 31792578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of oxidative stress status and antioxidant capacity in patients with painful bladder syndrome/interstitial cystitis: preliminary results of a randomised study.
    Ener K; Keske M; Aldemir M; Özcan MF; Okulu E; Özayar A; Ergin M; Doluoğlu ÖG; Çakmak S; Erel Ö
    Int Urol Nephrol; 2015 Aug; 47(8):1297-302. PubMed ID: 26049975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary nerve growth factor correlates with the severity of urgency and pain.
    Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH
    Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Yu WR; Jiang YH; Jhang JF; Kuo HC
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
    Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
    Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P2X7 Receptor Expression in Peripheral Blood Monocytes Is Correlated With Plasma C-Reactive Protein and Cytokine Levels in Patients With Type 2 Diabetes Mellitus: a Preliminary Report.
    Wu H; Nie Y; Xiong H; Liu S; Li G; Huang A; Guo L; Wang S; Xue Y; Wu B; Peng L; Song M; Li G; Liang S
    Inflammation; 2015 Dec; 38(6):2076-81. PubMed ID: 26021292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.
    Yu WR; Jiang YH; Jhang JF; Kuo HC
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
    Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
    Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Water Avoidance Stress on serum and urinary NGF levels in rats: diagnostic and therapeutic implications for BPS/IC patients.
    Dias B; Serrão P; Cruz F; Charrua A
    Sci Rep; 2019 Oct; 9(1):14113. PubMed ID: 31575913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome.
    Jiang YH; Jhang JF; Ho HC; Chiou DY; Kuo HC
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
    Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
    Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis.
    Xiao H; Wang T; Gao B; Liu J; Li S; Ma J
    Neurourol Urodyn; 2024 Mar; 43(3):754-766. PubMed ID: 38356381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.